12-102839031-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_StrongBS2
The NM_000277.3(PAH):c.*144A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000828 in 723,064 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★★).
Frequency
Genomes: 𝑓 0.00041 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00094 ( 8 hom. )
Consequence
PAH
NM_000277.3 3_prime_UTR
NM_000277.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.267
Genes affected
PAH (HGNC:8582): (phenylalanine hydroxylase) This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 12-102839031-T-C is Benign according to our data. Variant chr12-102839031-T-C is described in ClinVar as [Uncertain_significance]. Clinvar id is 657680.Status of the report is reviewed_by_expert_panel, 3 stars. We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1}.
BS2
High Homozygotes in GnomAdExome4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAH | NM_000277.3 | c.*144A>G | 3_prime_UTR_variant | 13/13 | ENST00000553106.6 | NP_000268.1 | ||
PAH | NM_001354304.2 | c.*144A>G | 3_prime_UTR_variant | 14/14 | NP_001341233.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAH | ENST00000553106 | c.*144A>G | 3_prime_UTR_variant | 13/13 | 1 | NM_000277.3 | ENSP00000448059.1 | |||
PAH | ENST00000307000 | c.*144A>G | 3_prime_UTR_variant | 14/14 | 5 | ENSP00000303500.2 |
Frequencies
GnomAD3 genomes AF: 0.000407 AC: 62AN: 152250Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
62
AN:
152250
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000941 AC: 537AN: 570696Hom.: 8 Cov.: 7 AF XY: 0.00118 AC XY: 362AN XY: 306426
GnomAD4 exome
AF:
AC:
537
AN:
570696
Hom.:
Cov.:
7
AF XY:
AC XY:
362
AN XY:
306426
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000407 AC: 62AN: 152368Hom.: 0 Cov.: 33 AF XY: 0.000617 AC XY: 46AN XY: 74514
GnomAD4 genome
AF:
AC:
62
AN:
152368
Hom.:
Cov.:
33
AF XY:
AC XY:
46
AN XY:
74514
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
69
AN:
3476
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1Benign:3
Revision: reviewed by expert panel
LINK: link
Submissions by phenotype
Phenylketonuria Uncertain:1Benign:2
Uncertain significance, reviewed by expert panel | curation | ClinGen PAH Variant Curation Expert Panel | Dec 23, 2020 | The NM_000277.3(PAH):c.*144A>G (ClinVar variant ID 657680) is a 3’ UTR variant in PAH. The variant has been previously reported as a single heterozygous variant in a proband with classic PKU (PMID: 20188615), with plasma Phe 1105 umol/L; BH4 deficiency does not appear to have been formally excluded (PP4). The authors speculated that the variant could “either affect the half life of the mRNA or its translation efficiency,†but did not perform functional validation studies. The variant was absent in the mother, who was unaffected, and present as a single heterozygous variant in the father, who was also unaffected. The authors were unable to detect a second variant in the (affected) proband, which they argued could be due to it being “located in PAH intronic regions not covered in the screening strategy.†It has also been found as a single heterozygous variant in a screening study of 3,552 healthy Japanese adults (PMID: 30887117). In ClinVar (ClinVar variant ID 657680), it is classified as VUS by one lab and Likely Benign by one lab, based on the above literature reports and uncertain functional consequences. Four heterozygotes and zero homozygotes are present for the variant in gnomAD; corresponding to a global AF of 0.000127 and maximum population frequency of 0.00128 (East Asian population), less than the 0.002 frequency threshold for use of BS1 and greater than the 0.0002 frequency threshold for use of PM2. The variant is predicted to not significantly alter splicing by multiple predictors (Splice AI score 0.00, MaxEntScan score variation 0.00%) (BP4). Classification: VUS Supporting Criteria: PP4; BP4 - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 21, 2023 | - - |
PAH-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 08, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at